Paratek pharmaceuticals, inc. (PRTK)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Net loss

-128,790

-112,356

-

-

-

-

-

-

-

-

-

Net loss

-

-

-89,069

-111,636

-70,860

-17,835

-4,653

-12,016

-3,880

-9,303

-21,800

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization and accretion

-1,292

-1,066

1,268

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

2,303

714

196

98

229

357

500

550

Stock-based compensation expense

14,295

25,492

16,902

10,792

5,062

706

249

2,929

4,405

1,879

1,367

Noncash interest expense

3,480

2,792

406

241

548

770

297

-

-

-

-

Impairment of intangible assets

-

107

743

-

2,860

0

0

-

-

-

-

Changes in fair value of contingent consideration

-

-71

-584

-345

-3,560

-

-

-

-

-

-

Loss on convertible note

-

-

-

-

-

-

-2,040

-

-

-

-

Loss on equity issuance associated with convertible notes

-

-

-

-

-

-

-2,948

-

-

-

-

Loss on exchange of non-convertible notes for common stock

-

-

-

-

-

-9,020

-

-

-

-

-

Loss (gain) on mark-to-market on convertible notes and preferred stock warrants

-

-

-

-

-

-120

8,051

-

-

-

-

Other gains, net

-

-

-

-

-17

3

172

-

-

-

-

Amortization of loan costs

-

-

-

-

-

-

-

-

-

-

28

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

47

Amortization of lease liability

-

-

-

-

-

-

-

-191

-316

-430

-281

Gain on disposals of fixed assets

-

-

-

-

-

-

-

0

-2

-2

-

Remeasurement of preferred stock warrants

-

-

-

-

-

-

-

-

-

-

200

Loss on disposals of fixed assets

-

-

-

-

-

-

-

-

-

-

-157

Gain on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

111

Amortization of premium on available for sale securities

-

-

-

-

-

-

-

-561

-1,250

-1,451

-1,395

Impairment of goodwill

-

-

-

-

-

-

-

0

0

-

-

Changes in operating assets and liabilities
Accounts receivable, prepaid, and other current assets

11,228

-4,440

4,833

-4,960

2,705

4,764

-203

-

-

-

-

Purchase of prepaid interest - marketable securities

239

715

-

-

-

-

-

-

-

-

-

Inventories

10,856

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use asset

-721

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

374

-641

-4,223

2,062

14,021

-6,401

1,448

-

-

-

-

Operating lease liability

-1,718

-

-

-

-

-

-

-

-

-

-

Other liabilities and other assets

-1,208

-839

-816

2,475

779

-

575

-

-

-

-

Deferred revenue

-

-

-

-

-

-342

-191

0

-7,292

-12,500

19,792

Net cash used in operating activities

-

-

-

-94,098

-54,682

-18,533

-6,359

-

-

-

-

Prepaid and other current assets

-

-

-

-

-

-

-

6,211

2,023

-24

-455

Other assets

-

-

-

-

-

-

-

-38

-770

-18

18

Accounts payable

-

-

-

-

-

-

-

14

389

-130

154

Accrued liabilities

-

-

-

-

-

-

-

-558

631

-1,059

-705

Net cash used in operating activities

-134,045

-81,179

-78,574

-

-

-

-

-15,205

-5,707

-19,548

830

Investing activities
Purchase of fixed assets

239

60

1,117

690

856

-

-

-

-

-

-

Cash acquired in connection with the Merger

-

-

-

-

-

13,688

-

-

-

-

-

Purchases of property and equipment

-

-

-

-

-

-

-

43

59

65

318

Purchase of marketable securities

102,207

292,864

180,289

135,799

-

-

-

41,037

52,175

106,618

128,324

Proceeds from maturities of marketable securities

237,000

165,050

131,250

60,106

-

-

-

-

-

-

-

Proceeds from sales of marketable securities

-

-

7,499

-

-

-

-

-

-

-

-

Cash and cash equivalents received from the Merger

-

-

-

-

-

-

-

-

-

-

47,987

Net cash provided by investing activities

134,554

-127,874

-42,657

-

-

-

-

5,170

1,266

16,068

14,652

Financing activities
Proceeds from maturities of marketable securities

-

-

-

-

-

-

-

46,250

53,500

122,751

95,307

Decrease in restricted cash

-

-

-

1,626

253

-

-

-

-

-

-

Other investing activities

-

-

-

-

-

21

-396

-

-

-

-

Net cash used in investing activities

-

-

-

-74,757

-603

13,667

396

-

-

-

-

Proceeds from bridge loanrelated party

-

-

-

-

-

5,100

-

-

-

-

-

Proceeds from issuance of non-convertible note

-

-

-

-

-

5,480

-

-

-

-

-

Proceeds from the issuance of long-term convertible debt, net of costs

-

-

320

-

-

-

4,806

-

-

-

-

Proceeds from the issuance of long-term debt, net of costs

-

9,950

19,915

19,574

19,205

-

-

-

-

-

-

Proceeds from employee stock purchase plan

509

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

286

82,795

11

247

-

1

-

-

-

-

Payments on long-term debt

-

-

-

-

-

-

-

-

-

-

3,353

Proceeds from sale of common stock, net of costs

26,559

51,517

-

70,930

71,279

89,761

-

38,744

1,380

169

470

Net cash provided by financing activities

57,622

220,727

103,030

-

-

-

-

38,744

1,380

169

-2,883

Net increase in cash, cash equivalents and restricted cash

58,131

11,674

-

-

-

-

-

-

-

-

-

Refund of prefunding for financing

-

-

-

-

-

831

-1,352

-

-

-

-

Net cash provided by financing activities

-

-

-

90,515

90,731

99,510

6,159

-

-

-

-

Net increase in cash, cash equivalents and restricted cash

-

-

-18,201

-

-

-

-

-

-

-

-

Net increase (decrease) in cash

-

-

-

-78,340

35,446

94,644

196

28,709

-3,061

-3,311

12,599

Supplemental disclosure of noncash financing activities
Fair value of warrants issued

-

130

79

271

288

-

-

-

-

-

-

Settlement of bridge loan

-

-

-

-

-

5,100

-

-

-

-

-

Conversion of prefunding to non-convertible note

-

-

-

-

-

520

-

-

-

-

-

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest

15,960

9,310

3,705

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

1,582

292

-

-

5

9

13

136

Purchases of equipment included in accrued expenses

339

-

-

-

-

-

-

-

-

-

-

Convertible Debt [Member]
Proceeds from the issuance of long-term debt, net of costs

-

158,974

-

-

-

-

-

-

-

-

-

Royalty Backed Loan Agreement [Member]
Proceeds from the issuance of long-term debt, net of costs

30,554

-

-

-

-

-

-

-

-

-

-